Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

4SC's Partner Yakult Honsha Starts Clinical Phase I Study in Pancreatic Tract Cancer Patients
Friday, June 26, 2015
Safety, tolerability and efficacy of resminostat in combination with S-1 chemotherapy will be investigated in various dosing schemes in order to determine dose regimen for potential subsequent Phase II trials in advanced pancreatic and/or biliary tract cancer.

Study Finds Addition of Epigenetic Data Improves Predictions of Complex Traits
Friday, June 26, 2015
Researchers reported that combining genetic and epigenetic associations can bolster phenotypic predictions.

Juniper Appointed Partner for Cancer Drug Delivery Platform
Thursday, June 25, 2015
Long-term collaboration with OxSonics to support the development, scale-up, and GMP manufacturing of “sono-sensitive particles.”

Kite Pharma and bluebird bio Announce Strategic Collaboration
Thursday, June 25, 2015
Collaboration combines bluebird bio's gene editing and lentiviral gene delivery technologies and Kite's TCR capabilities and exclusive rights to a TCR directed against the HPV-16 E6 oncoprotein.

Expanding the DNA Alphabet: 'Extra' DNA Base Found to be Stable in Mammals
Thursday, June 25, 2015
A rare DNA base, previously thought to be a temporary modification, has been shown to be stable in mammalian DNA, suggesting that it plays a key role in cellular function.

Broad Institute & Google Genomics Combine Bioinformatics and Computing Expertise
Thursday, June 25, 2015
Both companies explore how to break down major technical barriers that increasingly hinder biomedical research.

Stopping a Single Enzyme Could Help Treat Leukemia
Wednesday, June 24, 2015
EPFL scientists show how inactivating a single enzyme could effectively eradicate an aggressive form of leukemia. The principles could apply to other cancers as well.

Evo-Engineered CRISPR-Cas9s Hit More Gene-Editing Targets
Wednesday, June 24, 2015
Scientists have engineered a more effective CRISPR- Cas9 system paving the way for more advanced applications.

Quotient Clinical Begins Prostate Cancer Project for Druggability Technologies
Wednesday, June 24, 2015
The program will assess new formulations using DRGT’s proprietary Super-API technology, and aims to reduce dose and address food effects associated with the drug.

<< 9 10 11 12 13 14 15 >>
Showing Results 111 - 120 of 9746
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!